{"date":"2026-09-11","count":8,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-7827-2026-09-11-1939-3e8d45","company_id":"7827","company":"漢康-KY創","market":"上市","industry":"生技醫療","date":"2026-09-11","time":"19:39:04","subject":"公告本公司限制員工權利新股收足股款暨增資基準日","clause":"第51款","fact_date":"2026-09-11","cite_as":"公開資訊觀測站重大訊息：漢康-KY創（7827），2026-09-11 19:39，「公告本公司限制員工權利新股收足股款暨增資基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-8432-2026-09-11-1919-p67uuk","company_id":"8432","company":"東生華","market":"上櫃","industry":"生技醫療","date":"2026-09-11","time":"19:19:24","subject":"公告本公司內部稽核主管異動","clause":"第8款","fact_date":"2026-09-11","cite_as":"公開資訊觀測站重大訊息：東生華（8432），2026-09-11 19:19，「公告本公司內部稽核主管異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4120-2026-09-11-1818-ius1vi","company_id":"4120","company":"友華","market":"上櫃","industry":"生技醫療","date":"2026-09-11","time":"18:18:12","subject":"代子公司Cyntec Co., Ltd 依公開發行公司資金貸與及背書保證處理準則第二十二條第一項第二款公告","clause":"第23款","fact_date":"2026-09-11","cite_as":"公開資訊觀測站重大訊息：友華（4120），2026-09-11 18:18，「代子公司Cyntec Co., Ltd 依公開發行公司資金貸與及背書保證處理準則第二十二條第一項第二款公告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4732-2026-09-11-1614-16u2prg","company_id":"4732","company":"彥臣","market":"興櫃","industry":"生技醫療","date":"2026-09-11","time":"16:14:53","subject":"代子公司公告「COMPOSITION AND METHOD FOR TREATINGA DRUG-RESISTANT CANCER用於治療抗藥性癌症的組合物和方法」取得韓國發明專利","clause":"第44款","fact_date":"2026-09-11","cite_as":"公開資訊觀測站重大訊息：彥臣（4732），2026-09-11 16:14，「代子公司公告「COMPOSITION AND METHOD FOR TREATINGA DRUG-RESISTANT C」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1762-2026-09-11-1509-t3bsot","company_id":"1762","company":"中化生","market":"上市","industry":"生技醫療","date":"2026-09-11","time":"15:09:40","subject":"公告本公司財務主管、會計主管、公司治理主管及代理發言人異動","clause":"第8款","fact_date":"2026-09-11","cite_as":"公開資訊觀測站重大訊息：中化生（1762），2026-09-11 15:09，「公告本公司財務主管、會計主管、公司治理主管及代理發言人異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6936-2026-09-11-1507-10qn6yl","company_id":"6936","company":"永鴻生技","market":"上市","industry":"生技醫療","date":"2026-09-11","time":"15:07:10","subject":"公告本公司更換股務代理機構案經集保公司准予備查","clause":"第51款","fact_date":"2026-09-11","cite_as":"公開資訊觀測站重大訊息：永鴻生技（6936），2026-09-11 15:07，「公告本公司更換股務代理機構案經集保公司准予備查」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4142-2026-09-11-1450-5xucof","company_id":"4142","company":"國光生","market":"上市","industry":"生技醫療","date":"2026-09-11","time":"14:50:25","subject":"本公司受邀參加台新證券舉辦法人說明會","clause":"第12款","fact_date":"2026-09-16","cite_as":"公開資訊觀測站重大訊息：國光生（4142），2026-09-11 14:50，「本公司受邀參加台新證券舉辦法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6523-2026-09-11-1403-8ih4m5","company_id":"6523","company":"達爾膚","market":"上櫃","industry":"生技醫療","date":"2026-09-11","time":"14:03:32","subject":"本公司網路資安事件說明","clause":"第26款","fact_date":"2026-09-11","cite_as":"公開資訊觀測站重大訊息：達爾膚（6523），2026-09-11 14:03，「本公司網路資安事件說明」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}